Anti-obesity drugs fatten Novo Nordisk profits

Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of its anti-diabetes and anti-obesity treatments Ozempic and Wegovy.

Psychology & Psychiatry

Men doing more family caregiving could lower their risk of suicide

Colorado State University Professor of Psychology Silvia Sara Canetto has spent many years researching patterns and meanings of suicide by culture, trying to make sense of the variability in women's and men's suicide mortality ...

page 1 from 4